20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T4584 | BMS-813160 | BMS 813160 | CCR |
BMS-813160 is the first dual CCR2/CCR5 antagonist to enter Clinical development for cardiovascular. | |||
T36716 | RO0270608 | RO0270608 | |
RO0270608, the active metabolite of R411, is a dual α4β1/α4β7 integrin antagonist with anti-inflammatory activity[1][2]. | |||
T61807 | 5-HT6/7 antagonist 1 | Dopamine Receptor , 5-HT Receptor | |
5-HT6/7 antagonist 1 is a dual 5-HT6/7/2A and D2 receptor antagonist for the study of dementia and Alzheimer's disease. | |||
TQ0029 | ASTX660 | IAP | |
ASTX660 is an orally bioavailable dual antagonist of cIAP and XIAP. | |||
T62420 | P2Y2R/GPR17 antagonist 1 | GPR | |
P2Y2R/GPR17 antagonist 1 (Compound 14m) is a dual P2Y2R (IC50: 3.17 μM) and GPR17 (IC50: 1.67 μM) antagonist. | |||
T2710 | TCS 1102 | OX Receptor | |
TCS 1102 is an effective, dual orexin receptor antagonist (Ki: 0.2/3 nM for OX2/1 receptors). | |||
T10914 | Cyclodrine hydrochloride | AChR | |
Cyclodrine hydrochloride is a dual cholinergic muscarinic receptor (mAChR) and nicotinic receptor (nAChR) antagonist that can be used in the study of neurologically related diseases. | |||
T67782 | Daridorexant hydrochloride | Nemorexant hydrochloride,Quviviq | OX Receptor |
Daridorexant hydrochloride (Nemorexant hydrochloride) is a New Dual Orexin Receptor Antagonist. Daridorexant hydrochloride can be used for Insomnia research. | |||
T38144 | Elinzanetant | Neurokinin receptor | |
Elinzanetant is a dual antagonist of neurokinin (NK) receptors 1 and 3 and modulates reproductive hormone secretion. | |||
T5500 | DORA-22 | OX Receptor | |
DORA-22 is a dual orexin receptor antagonist, improves mild stress-induced insomnia with minimal effect on memory | |||
T14078 | AB928 | Adenosine Receptor | |
AB928 is an orally bioavailable, selective dual adenosine receptor (A2aR/A2bR) antagonist. It has immunomodulatory activity[1]. | |||
T24827 | SR 16832 | SR-16832,SR16832 | PPAR |
SR 16832 is a dual-site PPARγ inhibitor. It also inhibits the binding of endogenous ligands and transcriptional activity of PPARγ, more effectively than the orthosteric covalent antagonist GW 9662 and T 0070907. | |||
T6242 | Rupatadine Fumarate | Rinialer,Rupafin,Alergoliber | PAFR , Autophagy , Histamine Receptor |
Rupatadine Fumarate (Rinialer) (UR-12592 Fumarate) is a potent dual PAF/H1 antagonist with Ki of 0.55/0.1 uM. | |||
T5310 | TR-14035 | MDK-1191 | Integrin |
TR-14035 (MDK-1191) is a dual antagonist of α4β7/α4β1 integrins (IC50s: 7/87nM). | |||
T16854 | SB-674042 | SB674042 | OX Receptor |
SB-674042 is a potent and selective dual antagonist of the non-peptide orexigenic peptides OX1 and OX2 receptors, with IC50s of 3.76 nM and 531 nM, respectively.SB-674042 can be used for the treatment of depression. | |||
T17232 | Vidupiprant | AMG 853 | Prostaglandin Receptor |
Vidupiprant (AMG 853) is an effective dual antagonist of CRTH2 and prostanoid D receptor with IC50s of 8 nM and 35 nM in human plasma. Vidupiprant can be used in studies about the treatment of asthma. | |||
T12596 | (4E)-SUN9221 | 5-HT Receptor , Adrenergic Receptor | |
(4E)-SUN9221 is a potent dual α1-adrenergic receptor and 5-HT2 receptor antagonist that shows antihypertensive and antiplatelet aggregation activity in hypertensive rats. | |||
TQ0297 | Cenicriviroc | TAK-652,TBR-652 | HIV Protease , CCR |
Cenicriviroc (TAK-652) is an orally active, dual antagonist of CCR2/CCR5. It also inhibits both HIV-1 and HIV-2, and displays potent anti-infective and anti-inflammatory activity. | |||
T5355 | Sparsentan | RE-021,DARA-a | RAAS , Endothelin Receptor |
Sparsentan (DARA-a) is a first-in-class orally active and highly potent dual endothelin A and angiotensin II receptor antagonist(Ki of 9.3 and 0.8 nM, respectively) | |||
T6265 | Bosentan (hydrate) | Bosentan Hydrate,Benzenesulfonamide,Actelion,Ro 47-0203 | Endothelin Receptor |
Bosentan hydrate (Ro 47-0203) is a competitive and dual antagonist of endothelin-1 at the endothelin-A (ET-A) and endothelin-B (ET-B) receptors. |